ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 72 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $12,001 | -77.1% | 9,646 | -80.7% | 0.00% | – |
| Q4 2023 | $52,390 | -84.7% | 49,895 | 0.0% | 0.00% | – |
| Q3 2023 | $341,782 | -24.6% | 49,895 | +14.1% | 0.00% | – |
| Q2 2023 | $453,574 | +166.4% | 43,739 | +107.8% | 0.00% | – |
| Q1 2023 | $170,278 | -46.2% | 21,048 | +4.7% | 0.00% | – |
| Q4 2022 | $316,717 | +2.8% | 20,109 | +2.5% | 0.00% | – |
| Q3 2022 | $308,000 | +24.7% | 19,624 | +10.9% | 0.00% | – |
| Q2 2022 | $247,000 | -13.6% | 17,689 | +6.6% | 0.00% | – |
| Q1 2022 | $286,000 | +24.9% | 16,601 | +5.6% | 0.00% | – |
| Q4 2021 | $229,000 | -18.5% | 15,725 | +0.7% | 0.00% | – |
| Q3 2021 | $281,000 | +157.8% | 15,618 | +153.0% | 0.00% | – |
| Q2 2021 | $109,000 | +1716.7% | 6,172 | +11.8% | 0.00% | – |
| Q1 2020 | $6,000 | -40.0% | 5,519 | 0.0% | 0.00% | – |
| Q4 2019 | $10,000 | +66.7% | 5,519 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -50.0% | 5,519 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -69.2% | 5,519 | -15.0% | 0.00% | – |
| Q1 2019 | $39,000 | -18.8% | 6,495 | 0.0% | 0.00% | – |
| Q4 2018 | $48,000 | -15.8% | 6,495 | +64.1% | 0.00% | – |
| Q3 2018 | $57,000 | -27.8% | 3,959 | 0.0% | 0.00% | – |
| Q2 2018 | $79,000 | +12.9% | 3,959 | -0.7% | 0.00% | – |
| Q1 2018 | $70,000 | -48.5% | 3,986 | -27.4% | 0.00% | – |
| Q4 2017 | $136,000 | -6.8% | 5,491 | -3.2% | 0.00% | – |
| Q3 2017 | $146,000 | +2.8% | 5,672 | +8.0% | 0.00% | – |
| Q2 2017 | $142,000 | +79.7% | 5,254 | +98.3% | 0.00% | – |
| Q1 2017 | $79,000 | +5.3% | 2,649 | -3.8% | 0.00% | – |
| Q4 2016 | $75,000 | +78.6% | 2,753 | +68.1% | 0.00% | – |
| Q3 2016 | $42,000 | +35.5% | 1,638 | 0.0% | 0.00% | – |
| Q2 2016 | $31,000 | – | 1,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,399,034 | $49,422,000 | 10.17% |
| VR Adviser, LLC | 4,563,962 | $66,360,000 | 9.07% |
| COMMODORE CAPITAL LP | 2,672,346 | $38,856,000 | 9.00% |
| TCG Crossover Management, LLC | 1,082,213 | $15,735,000 | 7.37% |
| Foresite Capital Management V, LLC | 1,258,243 | $18,295,000 | 4.50% |
| Parkman Healthcare Partners LLC | 1,025,522 | $14,911,000 | 3.29% |
| Aisling Capital Management LP | 634,455 | $9,225,000 | 3.25% |
| GREAT POINT PARTNERS LLC | 800,000 | $11,632,000 | 2.58% |
| Samsara BioCapital, LLC | 794,171 | $11,547,000 | 2.24% |
| Affinity Asset Advisors, LLC | 400,000 | $5,816,000 | 2.11% |